Description

SUSTAMIX 250 INJ 10ML

Indications

SUSTAMIX 250 INJ 10ML is primarily indicated for the treatment of various conditions that require a combination of essential amino acids and other nutrients. It is commonly used in clinical settings for patients who are unable to meet their nutritional needs through oral intake alone. This includes patients undergoing surgery, those with severe burns, or individuals suffering from chronic illnesses that impair nutrient absorption. SUSTAMIX is also beneficial in supporting recovery in critically ill patients and in managing conditions such as malnutrition and cachexia.

Mechanism of Action

The mechanism of action of SUSTAMIX 250 INJ involves the provision of a balanced mixture of amino acids, which are the building blocks of proteins. These amino acids play a crucial role in various metabolic processes, including tissue repair and regeneration, immune function, and the synthesis of hormones and enzymes. By supplying the body with essential and non-essential amino acids, SUSTAMIX helps to restore and maintain nitrogen balance, which is critical in the recovery phase of illness or injury. Additionally, the formulation may include other nutrients that support metabolic functions and enhance overall health.

Pharmacological Properties

SUSTAMIX 250 INJ contains a well-balanced composition of amino acids, including both essential amino acids (EAAs) that the body cannot synthesize and non-essential amino acids (NEAAs) that can be produced endogenously. The pharmacokinetics of SUSTAMIX indicate that following administration, the amino acids are rapidly distributed throughout the body, with peak plasma concentrations occurring within a few hours. The metabolic pathways involved in the utilization of these amino acids include transamination and deamination, which facilitate their incorporation into proteins and other nitrogen-containing compounds. The formulation is designed for parenteral administration, ensuring that the nutrients are delivered directly into the bloodstream, thus bypassing the gastrointestinal tract.

Contraindications

SUSTAMIX 250 INJ is contraindicated in patients with known hypersensitivity to any of its components. It should also be avoided in individuals with certain metabolic disorders, such as phenylketonuria (PKU), where specific amino acids cannot be metabolized properly. Additionally, caution is advised in patients with severe liver or kidney dysfunction, as the metabolism and excretion of amino acids may be impaired in these conditions. It is essential to evaluate each patient’s medical history and current health status before initiating treatment with SUSTAMIX.

Side Effects

While SUSTAMIX 250 INJ is generally well tolerated, some patients may experience side effects. Common adverse reactions include local irritation at the injection site, such as redness, swelling, or pain. Systemic side effects may include nausea, vomiting, and diarrhea, particularly if the infusion is administered too rapidly. Rarely, allergic reactions may occur, manifesting as rash, itching, or anaphylaxis in sensitive individuals. It is important for healthcare providers to monitor patients for any adverse effects during and after administration.

Dosage and Administration

The dosage of SUSTAMIX 250 INJ should be individualized based on the patient’s clinical condition, age, weight, and nutritional requirements. In general, the recommended dosage for adults is 10 to 20 mL per day, administered intravenously. For pediatric patients, the dosage may vary and should be determined by a healthcare professional. SUSTAMIX should be infused slowly to minimize the risk of adverse reactions. It is crucial to follow the specific guidelines provided by the manufacturer and to adjust the dosage as necessary based on the patient’s response and laboratory parameters.

Interactions

SUSTAMIX 250 INJ may interact with certain medications, particularly those that affect amino acid metabolism or renal function. For instance, the concurrent use of corticosteroids may increase protein catabolism, potentially necessitating an adjustment in amino acid supplementation. Additionally, drugs that alter fluid balance, such as diuretics, may impact the efficacy of SUSTAMIX. Healthcare providers should review all medications that a patient is taking to identify potential interactions and adjust treatment plans accordingly.

Precautions

Before administering SUSTAMIX 250 INJ, it is essential to assess the patient’s overall health status, including renal and hepatic function. Patients with a history of metabolic disorders should be closely monitored during treatment. It is also important to ensure that the infusion is performed in a controlled setting, where healthcare professionals can observe for any adverse reactions. Regular monitoring of electrolyte levels and nitrogen balance is recommended to ensure that the patient is responding appropriately to therapy. In cases of fluid overload, particularly in patients with heart failure or renal impairment, caution should be exercised.

Clinical Studies

Clinical studies have demonstrated the efficacy of SUSTAMIX 250 INJ in improving nutritional status and promoting recovery in various patient populations. Research indicates that parenteral nutrition, including the use of amino acid solutions like SUSTAMIX, can significantly enhance protein synthesis and nitrogen retention in critically ill patients. In one study published in a peer-reviewed journal, patients receiving SUSTAMIX showed improved wound healing and reduced complications following surgery compared to those receiving standard care. Another study highlighted the benefits of amino acid supplementation in patients with severe burns, noting a decrease in infection rates and improved overall outcomes. These findings support the use of SUSTAMIX as an effective nutritional intervention in clinical practice.

Conclusion

SUSTAMIX 250 INJ 10ML is a valuable nutritional supplement designed to meet the needs of patients requiring parenteral nutrition. Its balanced formulation of amino acids and other nutrients plays a crucial role in promoting recovery and maintaining metabolic health. While generally safe, it is essential to administer SUSTAMIX under medical supervision and to monitor for any potential side effects or interactions. As with any medical treatment, individualized assessment and careful consideration of each patient’s unique circumstances are vital for optimal outcomes.